| |
Gastrointestinal
disorders are one of the commonest problems, of great concern to
the parents and doctors caring for infants and young children. Although
a large group of these disorders comprise various infections and
infestations of the gastrointestinal tract, an equal number of problems
are due to the so-called minor gastrointestinal upsets which occur
frequently and are a matter of grave concern in neonates and infants,
as their exact etiopathogenesis is not clear. A child is born with
an anatomically perfect gastrointestinal system, but physiological
maturity is acquired gradually, in months and perhaps years after
birth, as individual variations are always there. This physiological
immaturity coupled with poor intestinal motility and immaturity
of liver functions gives rise to intestinal upsets which reflect
in poor growth and development of the child. Due to these frequently
occurring gastrointestinal problems, parents and doctors get confused
and keep changing milk, or use antispasmodics and various enzymes
which do not really work. As a result, the child gradually begins
to lose weight.
A
formula which is simple, palatable and would relieve gases, colics
and at the same time stimulate digestion, absorption and stimulate
liver enzymes, would be an ideal remedy for these problems. Bonnisan
has been promoted as such a remedy. It has been studied by various
workers and is proved as an appetite stimulant, growth promoter1
and a very good carminative. This view has been thoroughly investigated
from various angles by a number of workers3-5. Bonnisan
contains Dill oil, ingredients of Liv.52, extracts of Tinospora
cordifolia, Piper longum,Emblica officinalis, Elettaria cardamomum,
Tribulus terrestris and Boerhaavia diffusa processed in
the fresh juices and decoctions of various digestive and hepatic
stimulants.
This study was conducted at Sir Padampat Mother and Child Health Institute,
Jaipur. One hundred and fifty newborns and infants up to 3 years of
age, suffering from gastrointestinal problems of various types and
not receiving any other medication, were taken up for the purpose
of this study.
|
Table
I: Dosage schedule
|
|
Sl.
No.
|
Age
group in months
|
Bonnisan
in t.s.f.
|
Frequency/day
|
|
1.
|
0
- 1
|
¼
- ½
|
3
- 4
|
|
2.
|
1
- 6
|
½
- 1
|
3
- 4
|
|
3.
|
6
- 12
|
1
- 2
|
3
- 4
|
|
4.
|
12
- 24
|
2
- 3
|
3
- 4
|
|
5.
|
24
- 36
|
3
- 4
|
3
- 4
|
There were 70 males and 80 females. Ninety were below the age of
one year (Table II)
|
Table
II : Age and sex distribution of the cases
|
| |
|
Age
Groups in Months
|
| Total
cases |
|
0-5
|
6-12
|
13-18
|
19-24
|
25-36
|
| Females |
70
|
30
|
10
|
10
|
10
|
10
|
| Males |
80
|
40
|
10
|
10
|
10
|
10
|
A
detailed history of complaints and other relevant information regarding
their previous growth and development were recorded on a planned
proforma. Bonnisan was started on these patients according to dosage
in Table I. These cases were followed up in the outdoor clinics
at first, weekly for one month, and then twice a month for six to
eight months. On every visit the relief of symptoms were enquired
into and confirmed with detailed examination. A weight record was
kept as an index of improvement.
The
mothers were instructed to bring their children to the hospital
immediately, if they observed any increase in or appearance of new
problems, before resorting to any home-remedies or consulting their
family doctor. Ten cases which did not conform strictly to the protocol
were not included in the study.
"Vague
illness" as in Table III is noted in those patients who have
nothing positive on examination but the parents complain that the
child is not playful like the others and he is either irritable
or dull. Another common problem for the parents, taken up here are
teething problems -which usually includes irritability, excessive
salivation, swollen gums and mild diarrhoea, at the time of eruption
of teeth.
|
Table
III : Results of therapy in various symptom groups
|
|
Symptom
Groups
|
No.
of cases
|
Percentage
to Total
|
Number
of cases showing definite improvement
|
Percentage
improvement
|
| Failure
to gain weight |
20
|
13.3
|
15
|
75.0
|
| Anorexia |
30
|
20.0
|
20
|
66.6
|
| Colics |
30
|
20.0
|
26
|
86.6
|
| Vomiting
/ Regurgitation |
15
|
10.0
|
10
|
66.6
|
| Mild
Diarrhoea/non-specific |
5
|
3.3
|
3
|
60.0
|
| Constipation |
15
|
10.0
|
14
|
93.3
|
| Abdominal
distension |
10
|
6.6
|
8
|
80.0
|
| Vague
illness |
10
|
6.6
|
7
|
70.0
|
| Post-antibiotic
dyspespsia |
5
|
3.3
|
5
|
100.0
|
| Teething
problems |
10
|
6.6
|
8
|
80.0
|
| Total |
150
|
-
|
116
|
77.3
|
Out
of hundred and fifty cases, 70 were females and 80 were males. The
distribution of cases age-wise is shown in Table II.
As
is evident from Table III, 116 cases with gastrointestinal problems
improved significantly with Bonnisan therapy. Bonnisan was effective
in most of the cases who were suffering from post-antibiotic dyspepsia
(100%), non-specific constipation (93.3%), and infantile colics
86.6%.
About
70-75% cases of failure to thrive and vague illness improved remarkably.
60-67% cases of anorexia, vomiting or regurgitation and mild non-specific
diarrhoea showed significant improvement.
Teething
problem which is a significant cause of anxiety among the parents
showed improvement in about 80% of cases.
The
response was the same in both the sexes. The acceptance for Bonnisan
was excellent in all the cases. No toxic side effect was seen in
any of the cases
Weight
gain is an index of good growth and development, which depends upon
the digestion, utilisation and assimilation of the nutrients provided
in the diet. Bonnisan by its digestive qualities helps in better
absorption and utilization of the food and by stimulating the various
digestive enzymes is believed to promote growth. Bonnisan is also
a safe, effective appetite- and growth-promoting agent4.
Hundred
and sixteen cases, i.e. 77.3% of the total cases taken up for the
study showed significant improvement in the symptoms and weight
gain which was above average expected for the particular age-group.
In the remaining cases the children did show some improvement but
the weight-gain was not above that expected for the age. Our findings
are in accordance with some authors6, but others have
shown 100% improvement in their cases7,8. The possible
explanation for this difference could be that they might have included
the cases who had normal weight gain at the time of study.
The
success rate seems to be impressive. Bonnisan definitely gives a
sense of relief to both patient and the doctor. Here one is faced
with an inevitable question - what in the drug has worked? Being
an Ayurvedic preparation, no definitive opinion can be given in
this respect.
Upon
clinical trial with Bonnisan, we have found satisfactory results
particularly in cases having non-specific symptoms like anorexia,
weight loss, irritability, regurgitation, and many other gastrointestinal
problems. Bonnisan can be prescribed without hesitation for non-specific
symptomatology with the caution that when these symptoms occur as
a part of a specific gastrointestinal pathology, it might work as
an adjunct to the specific therapy for that pathology.
-
Saxena,
S., Liv.52 in anorexia in paediatric practice Curr. med.
Pract. (1971): 1, 580.
-
Dhurandhar,
J., Bonnisan - A metabolic corrective in gastrointestinal disorders
of the newborn. Probe (1973): 2, 73.
-
Kulsreshtha,
J.K., Lal, G.M. and Laghate, V.D., Bonnisan in newborns and
infantsA preliminary study. Probe (1976): 2, 123.
-
Desai,
A.B. et al., Bonnisan - Metabolic tonic of the newborns.
Ind. Practit. (1976): 2, 119.
-
Ansari,
I.H., A clinical study on Bonnisan. Probe (1981): 3,
215.
-
Satyanarayana,
M., Murthy, P.S., A study on Bonnisan. Probe (1975):
3, 225.
-
Indira
Bai, K., Subba Rao, V.K., Subramanayam, M.U.G., Bonnisan a digestive
corrective and anabolic tonic for newborn infants. Probe
(1973): 3, 138.
-
Sinha,
K.P., Bonnisan - A clinical trial. Probe (1975): 1, 20.
|
 |